Cargando…
Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration
AIMS: A standardized sedation protocol for pulsed-field ablation (PFA) of atrial fibrillation (AF) through irreversible cellular electroporation has not been well established. We report our experience of a protocol for deep sedation with ketamine in spontaneous respiration during the PFA of AF. METH...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434732/ https://www.ncbi.nlm.nih.gov/pubmed/37494101 http://dx.doi.org/10.1093/europace/euad230 |
_version_ | 1785091973360648192 |
---|---|
author | Iacopino, Saverio Colella, Jacopo Dini, Daniele Mantovani, Lorenzo Sorrenti, Paolo Francesco Malacrida, Maurizio Filannino, Pasquale |
author_facet | Iacopino, Saverio Colella, Jacopo Dini, Daniele Mantovani, Lorenzo Sorrenti, Paolo Francesco Malacrida, Maurizio Filannino, Pasquale |
author_sort | Iacopino, Saverio |
collection | PubMed |
description | AIMS: A standardized sedation protocol for pulsed-field ablation (PFA) of atrial fibrillation (AF) through irreversible cellular electroporation has not been well established. We report our experience of a protocol for deep sedation with ketamine in spontaneous respiration during the PFA of AF. METHODS AND RESULTS: All consecutive patients undergoing PFA for AF at our center were included. Our sedation protocol involves the intravenous administration of fentanyl (1.5 mcg/kg) and midazolam (2 mg) at low doses before local anesthesia with lidocaine. A ketamine adjunct (1 mg/kg) was injected about 5 minutes before the first PFA delivery. We enrolled 66 patients (age = 59 ± 9 years, 78.8% males, body mass index = 28.8 ± 5 kg/m2, fluoroscopy time = 21[15–30] min, skin-to-skin time = 75[60–100] min and PFA LA dwell time = 25[22–28] min). By the end of the procedure, PVI had been achieved in all patients by means of PFA alone. The mean time under sedation was 56.4 ± 6 min, with 50 (76%) patients being sedated for less than 1 hour. A satisfactory Ramsey Sedation Scale level before ketamine infusion was achieved in all patients except one (78.8% of the patients with rank 3; 19.7% with rank 2). In all procedures, the satisfaction level was found to be acceptable by both the patient and the primary operator (Score = 0 in 98.5% of cases). All patients reported none or mild pain. No major procedure or anesthesia-related complications were reported. CONCLUSION: Our standardized sedation protocol with the administration of drugs with rapid onset and pharmacological offset at low doses was safe and effective, with an optimal degree of patient and operator satisfaction. CLINICAL TRIAL REGISTRATION: Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice (ATHENA). URL: http://clinicaltrials.gov/Identifier: NCT05617456. |
format | Online Article Text |
id | pubmed-10434732 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-104347322023-08-18 Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration Iacopino, Saverio Colella, Jacopo Dini, Daniele Mantovani, Lorenzo Sorrenti, Paolo Francesco Malacrida, Maurizio Filannino, Pasquale Europace Research Letter AIMS: A standardized sedation protocol for pulsed-field ablation (PFA) of atrial fibrillation (AF) through irreversible cellular electroporation has not been well established. We report our experience of a protocol for deep sedation with ketamine in spontaneous respiration during the PFA of AF. METHODS AND RESULTS: All consecutive patients undergoing PFA for AF at our center were included. Our sedation protocol involves the intravenous administration of fentanyl (1.5 mcg/kg) and midazolam (2 mg) at low doses before local anesthesia with lidocaine. A ketamine adjunct (1 mg/kg) was injected about 5 minutes before the first PFA delivery. We enrolled 66 patients (age = 59 ± 9 years, 78.8% males, body mass index = 28.8 ± 5 kg/m2, fluoroscopy time = 21[15–30] min, skin-to-skin time = 75[60–100] min and PFA LA dwell time = 25[22–28] min). By the end of the procedure, PVI had been achieved in all patients by means of PFA alone. The mean time under sedation was 56.4 ± 6 min, with 50 (76%) patients being sedated for less than 1 hour. A satisfactory Ramsey Sedation Scale level before ketamine infusion was achieved in all patients except one (78.8% of the patients with rank 3; 19.7% with rank 2). In all procedures, the satisfaction level was found to be acceptable by both the patient and the primary operator (Score = 0 in 98.5% of cases). All patients reported none or mild pain. No major procedure or anesthesia-related complications were reported. CONCLUSION: Our standardized sedation protocol with the administration of drugs with rapid onset and pharmacological offset at low doses was safe and effective, with an optimal degree of patient and operator satisfaction. CLINICAL TRIAL REGISTRATION: Advanced TecHnologies For SuccEssful AblatioN of AF in Clinical Practice (ATHENA). URL: http://clinicaltrials.gov/Identifier: NCT05617456. Oxford University Press 2023-07-26 /pmc/articles/PMC10434732/ /pubmed/37494101 http://dx.doi.org/10.1093/europace/euad230 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Research Letter Iacopino, Saverio Colella, Jacopo Dini, Daniele Mantovani, Lorenzo Sorrenti, Paolo Francesco Malacrida, Maurizio Filannino, Pasquale Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title | Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title_full | Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title_fullStr | Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title_full_unstemmed | Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title_short | Sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
title_sort | sedation strategies for pulsed-field ablation of atrial fibrillation: focus on deep sedation with intravenous ketamine in spontaneous respiration |
topic | Research Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434732/ https://www.ncbi.nlm.nih.gov/pubmed/37494101 http://dx.doi.org/10.1093/europace/euad230 |
work_keys_str_mv | AT iacopinosaverio sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT colellajacopo sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT dinidaniele sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT mantovanilorenzo sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT sorrentipaolofrancesco sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT malacridamaurizio sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration AT filanninopasquale sedationstrategiesforpulsedfieldablationofatrialfibrillationfocusondeepsedationwithintravenousketamineinspontaneousrespiration |